Latest current cash for RAIN: $33K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Rain Oncology (RAIN) currently reports a current cash of $33K as of June 2026. That compares with $16K in the prior-year period — up 97.9% year over year. Use the charts on this page to explore Rain Oncology's current cash history and peer comparisons.
Rain Oncology's current cash increased from $16K to $33K — a 97.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Rain Oncology reported $33K in current cash as of June 2026. That compares with $16K in the prior-year period — up 97.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $33K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Rain Oncology, and consider following RAIN for alerts when major investors trade the stock.
Rain Oncology is classified in the Healthcare sector. On current cash, it currently shows $33K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RAIN with unrelated industries.